2 Growth Stocks to Buy Hand Over Fist in February
Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in ...
Hosted on MSN4d
Lilly's profit forecast brings relief amid Zepbound miss
Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, a move investors said eases some concerns about signs of weakness in sales of its popular diabetes and weight-loss ...
Lilly’s Mounjaro and Zepbound contribute to big revenue boost, drugmaker says
Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.
BioWorld18d
Lilly’s Zepbound outpaces Wegovy as December logs 212 trial updates
Eli Lilly and Co. reported that its FDA-approved weight-loss drug Zepbound (tirzepatide) outperformed Novo Nordisk A/S’s Wegovy (semaglutide) in the phase IIIb Surmount-5 trial.
MM&M18d
Novo Nordisk’s amycretin cuts weight by 22% in early obesity trial
This hormone slows the rate of how the stomach is emptied and regulates blood sugar. Amycretin also works slightly differently than Eli Lilly’s Zepbound and Viking Therapeutics’ experimental VK-2735, ...
UPI20d
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
Related FDA approves weight-loss drug Zepbound to treat sleep apnea FDA says shortage of GLP-1 drug tirzepatide is over Merck reaches weight-loss drug deal worth up to $2 billion with China-based ...
phillyvoice.com20d
Ozempic and Wegovy are helping many Americans lose weight, but they also may have other beneficial uses
This class of drugs, known as glucagon-like peptide-1 receptor agonists, or GLP-1s, also includes Wegovy and Zepbound. GLP-1s were developed to treat diabetes, but they have become popular weight ...
The Verge20d
DOGE has an official government website.
There’s barely anything on it, but doge.gov is now a real website. And after I first published this, it got a new, cartoony image. Update: Added the new picture, but you can see the original in ...
CBS 620d
Capital Region woman loses 60 pounds, improves health with GLP-1 meds
CLIFTON PARK, N.Y. — Insiya Klapper, who lives in the Capital Region, has experienced a transformative year, shedding 60 pounds with the help of the GLP-1 medication, Zepbound. However ...
Global News20d
The Ozempic debate: Large study reveals the good and the bad
1:27 Ozempic can lower chances of multiple health conditions but comes with risks, study finds Ozempic, Wegovy, Zepbound and other drugs often used for weight loss may help lower the risk of a ...
Time20d
The Health Risks and Benefits of Weight-Loss Drugs
The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing ...